Trinity Biotech Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 144.0 | 118.7 | 98.7 |
| Cost of Goods Sold | 88.4 | 67.9 | 51.4 |
| Gross Profit | 55.7 | 50.8 | 47.3 |
| Gross Profit Margin | 38.6% | 42.8% | 48.0% |
| SG&A Expense | 77.3 | 42.4 | 39.9 |
| Depreciation & Amortization | 7.8 | 6.4 | 4.2 |
| Operating Income | (29.4) | 1.9 | 3.2 |
| Operating Margin | -- | 1.6% | 3.2% |
| Nonoperating Income | 0.5 | 1.2 | 1.1 |
| Nonoperating Expenses | 3.2 | 2.7 | 1.1 |
| Income Before Taxes | (32.1) | 0.4 | 3.3 |
| Income Taxes | 3.3 | (2.8) | 0.7 |
| Net Income After Taxes | (35.4) | 3.3 | 2.6 |
| Continuing Operations | (35.4) | 3.3 | 2.6 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (35.4) | 3.3 | 2.6 |
| Total Net Income | (35.4) | 3.3 | 2.6 |
| Net Profit Margin | -- | 2.8% | 2.6% |
| Diluted EPS from Total Net Income ($) | (1.86) | 0.19 | 0.35 |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
